{
    "clinical_study": {
        "@rank": "53777", 
        "arm_group": [
            {
                "arm_group_label": "vitamin A palmitate eye gel", 
                "arm_group_type": "Experimental", 
                "description": "0.1% vitamin A palmitate; Sinqi, Shenyang, China"
            }, 
            {
                "arm_group_label": "carbomer eye gel", 
                "arm_group_type": "Experimental", 
                "description": "0.2% Carbomer 940; Bausch & Lomb, Aschheim, Germany"
            }
        ], 
        "brief_summary": {
            "textblock": "Most of the patients under long application of anti-glaucoma eyedrops endure severe ocular\n      surface irritation, which interrupt their quality of life a lot. Lots of studies aimed to\n      search for new drugs for therapy. The investigators hypothesized that the artificial tears\n      containing vitamin A or carbomer may be a great substitute. Both of the two drugs were in\n      common use and had already been tested in animals."
        }, 
        "brief_title": "Study of Vitamin A and Carbomer in Comforting the Ocular Surface Irritations of Glaucoma Patients", 
        "completion_date": {
            "#text": "September 2013", 
            "@type": "Actual"
        }, 
        "condition": "Primary Open-angle Glaucoma", 
        "condition_browse": {
            "mesh_term": [
                "Glaucoma", 
                "Glaucoma, Open-Angle"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        - diagnosed primary open-angle glaucoma or normal tension glaucoma patients with\n        prostaglandin analogs treatment for more than one year.\n\n        Exclusion Criteria:\n\n          1. any systemic diseases which may cause ocular damage;\n\n          2. previous ocular trauma or surgery;\n\n          3. contact lens wear history in previous 6 months;\n\n          4. application of any artificial tears 3 months ago;\n\n          5. allergic to any of the drugs we used during examination."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "February 23, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02077231", 
            "org_study_id": "GlaucomaVitaminA"
        }, 
        "intervention": [
            {
                "arm_group_label": "vitamin A palmitate eye gel", 
                "description": "use one drop in the eye", 
                "intervention_name": "Vitamin A", 
                "intervention_type": "Drug", 
                "other_name": "vitamin A palmitate eye gel"
            }, 
            {
                "arm_group_label": "carbomer eye gel", 
                "description": "use one drop in the eye", 
                "intervention_name": "carbomer eye gel", 
                "intervention_type": "Drug", 
                "other_name": "Carbomer Eye Drops"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Vitamin A", 
                "Vitamins", 
                "Retinol palmitate", 
                "Carbopol 940"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "March 3, 2014", 
        "number_of_arms": "2", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "China: Ethics Committee"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "February 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "change of the density of conjunctival goblet cells", 
            "safety_issue": "Yes", 
            "time_frame": "change from Baseline in goblet cell density at 6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02077231"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Shanghai Jinshan Hospital", 
            "investigator_full_name": "Xiaodong Zhou", 
            "investigator_title": "Professor of Ophthalmology", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "tear film parameters changes in patients", 
                "safety_issue": "Yes", 
                "time_frame": "change from baseline in TBUT and Schirmer test at 6 months"
            }, 
            {
                "measure": "changes of ocular irritation in patients", 
                "safety_issue": "Yes", 
                "time_frame": "change from baseline in OSDI scores at 6 months"
            }
        ], 
        "source": "Shanghai Jinshan Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Xiaodong Zhou", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2011", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}